Didier Raoult A leading microbiology society has issued expressions of concern for four six papers from a group in France led by the controversial scientist Didier Raoult, whose lab is under investigation by the University of Aix Marseille for “serious malfunctions.” The move follows the release last month of a 157-page report by investigators related…
FastForward Innovations Limited (LSE:FFWD) | RNS | FastForward Inn Ltd proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
Covid-19: Fact-checking Macron s over-65s claim about the Oxford-AstraZeneca vaccine
By Reality Check team
image copyrightGetty Images
On the day the European Medicines Agency (EMA) approved the Oxford-AstraZeneca vaccine on 29 January for use for all age groups in the EU, French president Emmanuel Macron claimed that it was quasi-ineffective for people over 65.
He added that the early results we have are not encouraging for 60 to 65-year-old people concerning AstraZeneca .
But the UK government and British medical regulators strongly disagree.
So what is the evidence on the AstraZeneca (AZ) vaccine and older people?
Who s doing what?
Following Mr Macron s comments, France s Health Authority made an official recommendation on 2 February that the vaccine should not be used for people over 65. It said more studies were needed before it was rolled out to older age groups.
Investor Ideas Potcasts #523, Cannabis News and Stocks on the Move; (TSX: WEED) (NASDAQ: CGC) (OTC: PURA) (OTC: ALKM) (TSXV: ELXR)
Delta, Kelowna, BC - January 27, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
SHARE PODCAST:
Today s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com Potcast featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
About Elixxer Ltd. (
Elixxer is a Canadian public company listed on the TSX Venture Exchange (TSX-V: ELXR) and the US OTC-QB exchange (OTCQB: ELIXF).
Through its partners, Elixxer presently has significant interests in Australia, Jamaica, Switzerland, Italy and Canada.
For further information please contact: [email protected]
Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Notice Regarding Forward Looking Statements
This press release may contain forward-looking statements with respect to Elixxer and its operations, strategy, investments, financial performance and condition. These statements can generally be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “conti